CASI Pharmaceuticals (CASIF) Return on Capital Employed [ROCE] (2023 - 2025)
CASI Pharmaceuticals (CASIF) reported Return on Capital Employed [ROCE] of -299.58% for Q1 2025, down 250.30 percentage points from -49.28% a year earlier and down 121.05 percentage points from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Return on Capital Employed [ROCE] (2023 - 2025) Analysis & Trends
For FY2024, CASI Pharmaceuticals posted Return on Capital Employed [ROCE] of -141.41%, down 105.07 percentage points from FY2023.
- By year, Return on Capital Employed [ROCE] came in at -36.33% in FY2023 (-2.39 pp) and -33.94% in FY2022.
- The Q1 2025 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2023.
- Year over year, Return on Capital Employed [ROCE] has now declined in each of the last five quarters, with an average year-over-year change of -83.09 percentage points over the last five quarters.
- Per Business Quant data, the three quarters before Q1 2025 came in at -178.53% (Q4 2024), -73.62% (Q3 2024) and -62.30% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -299.58% |
| Dec 31, 2024 | -178.53% |
| Sep 30, 2024 | -73.62% |
| Jun 30, 2024 | -62.30% |
| Mar 31, 2024 | -49.28% |
| Dec 31, 2023 | -45.48% |
| Sep 30, 2023 | -57.02% |
| Jun 30, 2023 | -52.29% |
| Mar 31, 2023 | -43.80% |
API Access
CASI Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();